Endo appoints new R&D chief
This article was originally published in Scrip
Executive Summary
Endo – a speciality healthcare company developing medicines for pain management, urology, oncology and endocrinology indications – has named Dr Susan Hall chief scientific officer and global head of R&D and quality, effective 10 March 2014. Prior to joining the Dublin, Ireland-based firm Dr Hall was senior vice-president and global head of R&D at Valeant Pharmaceuticals. Furthermore, she has also held various R&D leadership positions at GlaxoSmithKline.